Care property investor and developer Assura announced on Friday that a development funding deal for a £31m cancer diagnostic and treatment centre in Guildford has reached financial close.
Genesis Cancer Care UK will operate and lease the building for the centre on a 30-year FRI lease with yearly, index-linked rent reviews.
Through a joint collaboration between GenesisCare and the Royal Surrey NHS Foundation Trust, the building, which is located next to the Royal Surrey County Hospital, will provide ‘cutting-edge’ oncology and cancer care services.
Two radiation treatment bunkers, one state-of-the-art MR-guided Linac and one conventional Linac, as well as diagnostic and a radiopharmacy facility for nuclear medicine imaging and treatment, will be located in the cancer centre.
The building is expected to receive a ‘Very Good’ BREEAM rating, with ‘Excellent’ for the energy element, and an EPC of A.
PV panels, LED lighting, and EV charging stations will be installed throughout the facility.
Assura has also launched an education and skills bursary package as part of its overall funding approach, and the centre will gain a new sensory garden from the building for patient and employee wellbeing.
Prime is developing the centre, which will be completed by Vinci Construction, with a practical deadline in Q4 2023.
Jonathan Murphy, CEO, said, “We are pleased to be working with Prime again to forward fund this scheme in Guildford.”
“This new, state-of-the-art facility will deliver services that ease the burden on the local NHS and help create additional capacity within existing NHS assets to address treatment backlogs.”
“This scheme is another step on our strategy to expand our offering, working with selected high-quality private providers who partner with the NHS as well as having a high sustainability and social impact.”
Assura shares gained 0.45% to 67p following the news in early morning trade on Friday.